Cargando…
Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs
The outbreak of Coronavirus disease 2019 (COVID-19) has evolved into an emergent global pandemic. Many drugs without established efficacy are being used to treat COVID-19 patients either as an offlabel/compassionate use or as a clinical trial. Although drug repurposing is an attractive approach with...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859465/ https://www.ncbi.nlm.nih.gov/pubmed/33542445 http://dx.doi.org/10.1038/s41397-021-00209-9 |